Friday, 27 October 2017

Merck tops profit estimates on Keytruda sales

(Reuters) - Merck & Co on Friday reported a quarterly profit that beat analysts' estimates, benefiting from sales of its immuno-oncology drug Keytruda.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)